Dr. Yuri Cheburkin

Angestellt, Head of Laboratory, Almazov National Medical Research Centre

Sankt-Petersburg, Russische Föderation

Fähigkeiten und Kenntnisse

Oncology
Molecular biology
Molecular Medicine
Molecular Genetics
Molecular diagnostics
Clinical Trial Management
Clinical Trials
Research and Development
R & D

Werdegang

Berufserfahrung von Yuri Cheburkin

  • Bis heute 5 Jahre und 5 Monate, seit 2019

    Head of Laboratory

    Almazov National Medical Research Centre

  • 2 Jahre und 3 Monate, Okt. 2016 - Dez. 2018

    Staff Scientist

    N.N.Petrov's Research Institute of Oncology

    Research in IVD for oncology

  • 2 Jahre und 2 Monate, Sep. 2014 - Okt. 2016

    Executive Director

    Dr.Filatov's Clinic

  • 3 Jahre und 7 Monate, Apr. 2013 - Okt. 2016

    Medical director

    MedWiser

  • 8 Monate, Juli 2012 - Feb. 2013

    Deputy Director

    Alkor Bio's Center of Diagnostic

  • 1 Jahr und 4 Monate, März 2011 - Juni 2012

    Chief Science Officer (CSO)

    Alkor Bio LLC

    the head of scientific research operations at companies performing significant scientific research projects

  • 1 Jahr und 9 Monate, Juli 2009 - März 2011

    CEO, General Manager

    IFE Russia / Pierrel Research Russia

  • 6 Monate, Feb. 2009 - Juli 2009

    Deputy CEO, Operational Director

    IFE Russia

  • 4 Monate, Nov. 2008 - Feb. 2009

    CRA

    IFE Russia

  • 2 Jahre und 7 Monate, Juni 2005 - Dez. 2007

    Scientist

    Max-Planck-Institut für Biochemie

    Personal projects: expression and characterization of proteins with incorporated non-canonical amino acids, orthogonal expression systems. Supervising of doctorand's projects. European/world patent pending.

  • 3 Jahre und 1 Monat, Juni 2002 - Juni 2005

    Postdoctoral associate

    group of "ROCHE Diagnostics" by MPI

    Structural research and anticancer drug discovery. Gene mutagenesis and expression of cancer targeted proteins. Crystallisation of the target-gene proteins.

  • 7 Jahre, Juli 1995 - Juni 2002

    Doctorand

    Max-Planck Institute for Biochemistry

    cDNA arrays profiling of oncogenes in human primary tumors and cancer cell lines (mostly receptor tyrosine kinases and phosphatases, like EGFR, HER2, VEGFR, FGFR4, AXL and others). Research in field of TK expression and functional mutations. Cloning and functional characterization of new genes involved in signal transductions and growth control of human cancer cells. Cell culture growth and manipulation, and "in vitro" signal transduction experiments. Have some publications, the european/world patent.

  • 3 Jahre und 2 Monate, Juni 1992 - Juli 1995

    PhD student

    Research Institute of Oncology (S-Petersburg, Russia)

Ausbildung von Yuri Cheburkin

  • S.-Petersburg Medicine Academy (former LSGMI)

    СПбГМА (бывш. ЛСГМИ)

Sprachen

  • Deutsch

    Grundlagen

  • Englisch

    Fließend

  • Russisch

    Muttersprache

  • Polnisch

    Gut

21 Mio. XING Mitglieder, von A bis Z